APTARGROUP, INC. (ATR) Financial Ratio Screen

NYSE Healthcare United States USD 8599M
FINANCIAL SCREEN PASSED*
Automated financial screen · activity assessed separately
APTARGROUP, INC. (ATR) passes all available checks in 2 implemented financial-ratio model(s). Its activity assessment is still in progress; this is not a Shariah verdict. Its debt proxy is 29.1% against the model threshold of 30%. The supplied classification is Healthcare (Medical Instruments & Supplies); mixed activities and revenue segments remain part of the activity assessment.

Track ATR screening changes

Get an email when this stock's published screening status or underlying ratios change.

MSCI new-inclusion financial-ratio snapshot

ATR financial screening at a glance

FINANCIAL SCREEN PASSED*Financial ratios shown separately from business review — not a fatwa
Debt ratio
29.1%
Pass vs 30%
Cash ratio
7.8%
Pass vs 30%
Receivables + cash
23.1%
Pass vs 30%
Impermissible income
0.3%
Pass vs 5%

Calculation date: 2026-08-31. Financial period used: December 2025. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.

Independent method comparison

What the available screens say

How MSCI, FTSE and S&P-style screens differ
Request this stock review
MSCI-styleFinancial criteria passedActivity is assessed separately
FTSE/Yasaar-styleFinancial criteria passedActivity is assessed separately
S&P-style provisionalNot yet availableRequired denominator or financial data is incomplete
Business activityAssessment pendingFinancial results do not determine business permissibility
Complete screening result: not yet completeA complete result requires both supported financial criteria and adequate activity evidence. This site does not issue a fatwa or official index decision.
Financial periodDecember 2025Calculation date2026-08-31S&P-style historynot availableLast activity reviewnot yet reviewed

The request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.

Business activity evidence

Activity assessment in progress

The supplied classification (Medical Instruments & Supplies) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.

Revenue segments: Not yet checked against an SEC annual filing.

Profile description reviewed: AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Sources to verify: Secondary company profile and classification · Issuer website · SEC issuer filings

A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.

Published-ratio reproductions (not certifications)

The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style leverage reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
MSCI 29.1%
/ 30%
7.8%
/ 30%
23.1%
/ 30%
0.31%
/ 5%
FINANCIAL SCREEN PASSED*
FTSE 29.1%
/ 33%
7.8%
/ 33%
23.1%
/ 50%
0.31%
/ 5%
FINANCIAL SCREEN PASSED*

Financial Highlights

P/E Ratio
24.3
Forward: 21.4
EPS
$5.56
Dividend Yield
143.0%
Payout: 34.1%
P/B Ratio
3.3
EV/EBITDA
12.3
EV: $9.9B
Revenue
$3.8B
Growth: 6.3%
Beta
0.4
Low volatility
Current Ratio
1.6

Profitability

Gross Margin 36.1%
Operating Margin 12.5%
Net Margin 9.2%
Return on Equity (ROE) 13.5%
Return on Assets (ROA) 6.1%

Cash Flow & Balance Sheet

Operating Cash Flow$570M
Free Cash Flow$295M
Total Debt$1.5B
Debt-to-Equity52.8
Current Ratio1.6
Total Assets$5.3B

Price & Trading

Last Close$134.72
50-Day MA$129.98
200-Day MA$126.09
Avg Volume468K
Beta0.4
52-Week Range
$103.23
$146.91

Financial data provenance and verification

The displayed fields were imported from yfinance on 2026-08-27 for the financial period December 2025. This is a secondary data feed and can differ from amended or newly filed statements.

Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.

About APTARGROUP, INC. (ATR)

CEO
Mr. Stephan B. Tanda
Employees
14,000
Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Exchange
NYSE
Market Cap (listing currency)
USD 8599M
Currency
USD

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Popular halal stock checks

Explore other frequently viewed automated stock screens and compare the available financial ratios.

Frequently Asked Questions

Is APTARGROUP, INC. (ATR) halal to invest in?

The current automated result is Financial screen passed; activity assessment pending. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.

What is APTARGROUP, INC.'s debt ratio?

APTARGROUP, INC.'s debt ratio is 29.1% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.

What are APTARGROUP, INC.'s key financial metrics?

APTARGROUP, INC. has a market capitalization of USD 8599M in its listing currency, trailing P/E ratio of 24.3, and revenue of $3.8B. The company maintains a gross margin of 36.1% and a net margin of 9.2%. Return on equity stands at 13.5%.

How often is the screening data updated?

Calculation date: 2026-08-31. Financial period: December 2025. These dates are shown separately because regenerating this page does not refresh the underlying data.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.